about
Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial.Pure exercise intolerance and ophthalmoplegia associated with the m.12,294G > A mutation in the MT-TL2 gene: a case reportCreatine kinase response to high-intensity aerobic exercise in adult-onset muscular dystrophy.Muscle glycogen synthesis and breakdown are both impaired in glycogenin-1 deficiency.Skeletal muscle metabolism during prolonged exercise in Pompe disease.Training improves oxidative capacity, but not function, in spinal muscular atrophy type III.Impaired glycogen breakdown and synthesis in phosphoglucomutase 1 deficiency.Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies.PGM1 deficiency: Substrate use during exercise and effect of treatment with galactose.Patients With Medium-Chain Acyl–Coenzyme A Dehydrogenase Deficiency Have Impaired Oxidation of Fat During Exercise but No Effect ofl-Carnitine SupplementationFat and carbohydrate metabolism during exercise in late-onset Pompe diseasel-Carnitine Improves Skeletal Muscle Fat Oxidation in Primary Carnitine DeficiencySkeletal muscle metabolism is impaired during exercise in glycogen storage disease type IIIExercise intolerance in Glycogen Storage Disease Type III: Weakness or energy deficiency?No effect of triheptanoin on exercise performance in McArdle diseaseGrowth and differentiation factor 15 as a biomarker for mitochondrial myopathySafety and efficacy of omaveloxolone in patients with mitochondrial myopathy: MOTOR trialImpaired fat oxidation during exercise in multiple acyl-CoA dehydrogenase deficiencyImpaired Fat Oxidation During Exercise in Long-Chain Acyl-CoA Dehydrogenase Deficiency Patients and Effect of IV-GlucoseFat oxidation is impaired during exercise in lipin-1 deficiency
P50
Q37658358-8423BDB8-0B51-407E-9839-91F7E95F456FQ42660002-A912A905-C25E-4B09-850D-E426F6AA8767Q43646427-11D4DEA9-8AC3-472E-9DB9-95523DCF2368Q47398596-89DFE8F2-4CB2-4D0C-8D28-8042E3E95772Q47896087-69C9EA4F-1765-49D2-9304-7562570FD8F6Q48015086-8F72DB41-CFE2-44F1-8E5A-6DD26FB1C423Q50204139-9B4F3A5D-9F64-4A79-8FD8-E34111B2B9ACQ50486375-5C23FDB3-53D4-492A-BF92-0D936D0A8ABEQ51140524-8CDDA35F-D223-4DA9-B480-75ADBFA53E8CQ61805259-AFC447EC-FD0E-4FE4-80FD-34DF489B6268Q61805275-2ACB5678-EFD2-4F9A-8B90-6FEDDF2EA458Q61877451-779FFD44-CA75-4506-A98A-6510C59954A3Q61877454-B0207F0D-A10D-42AF-BEE3-7625F1B37994Q61877456-B7D85504-22FB-4130-AC74-3793A993DA33Q90104172-61351972-44A9-4D73-B519-8CF45E13ED9AQ91026432-29BBC79F-3DC6-4271-864B-9520CAC38C21Q92379699-9A033D8C-9632-4DE1-90BB-74F9E2E2A12DQ93029719-6C7BF174-3C9D-424E-90F7-D489669C59EDQ93125849-E40BFA20-7DFB-487E-A9B2-32DED9E688B4Q93160989-BF2D34FB-1D2F-4731-88D5-B6791578D934
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Karen L Madsen
@ast
Karen L Madsen
@en
Karen L Madsen
@es
Karen L Madsen
@nl
Karen L Madsen
@sl
type
label
Karen L Madsen
@ast
Karen L Madsen
@en
Karen L Madsen
@es
Karen L Madsen
@nl
Karen L Madsen
@sl
prefLabel
Karen L Madsen
@ast
Karen L Madsen
@en
Karen L Madsen
@es
Karen L Madsen
@nl
Karen L Madsen
@sl
P106
P108
P21
P31
P496
0000-0003-0145-1084